Choksi Laboratories Ltd Financial Ratios
CHOKSILA · Healthcare · Current price ₹112
P/E ratio
51.4x
P/B ratio
3.0x
ROE
6.5%
ROCE
9.2%
Debt / Equity
1.20
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 51.4x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 3.0x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 6.5% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 9.2% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 1.20 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Choksi Laboratories Ltd's latest numbers.
Choksi Laboratories Ltd profitability
Choksi Laboratories Ltd generates a return on equity of 6.5% and a return on capital employed of 9.2%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 1.20 and a P/E of 51.4x, Choksi Laboratories Ltd is moderately leveraged. Our overall business-quality score for the company is 2.3 / 10.
Understand the ratios
More on Choksi Laboratories Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.